Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Yong Ai Li"'
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background Chemoresistance gradually develops during treatment of epithelial ovarian cancer (EOC). Metabolic alterations, especially in vivo easily detectable metabolites in paclitaxel (PTX)-resistant EOC remain unclear. Methods Xenograft mo
Externí odkaz:
https://doaj.org/article/9d511ecf7a084686853274d5812d3ceb
Publikováno v:
Translational Oncology, Vol 10, Iss 3, Pp 311-317 (2017)
Lung cancer is the most common fatal malignancy for both men and women and adenocarcinoma is the most common histologic type. Early diagnosis of lung cancer can significantly improve the survival rate of patients. This study aimed to investigate the
Externí odkaz:
https://doaj.org/article/f2861a1684bb4c84bb52f094203a82be
Autor:
Shu Hui Zhao, Xiao Liang Ma, Jing Lu, Yong Ai Li, Jin Wei Qiang, Feng Hua Ma, Hai Ming Li, Song Qi Cai
Publikováno v:
Academic Radiology. 28:e77-e85
Rationale and Objectives To investigate the feasibility of apparent diffusion coefficient (ADC) histogram analysis of primary advanced high-grade serous ovarian cancer (HGSOC) to predict patient response to platinum-based chemotherapy. Materials and
Autor:
Song-Qi Cai, Zhen-Yu Song, Min-Rong Wu, Jing-Jing Lu, Wen-Wen Sun, Feng Wei, Hai-Ming Li, Jin-Wei Qiang, Yong-Ai Li, Jian Zhu, Jian-Jun Zhou, Meng-Su Zeng
Publikováno v:
Academic radiology.
To investigate the value of magnetic resonance imaging (MRI) including diffusion-weighted imaging (DWI) findings in predicting mesenchymal transition (MT) high-grade serous ovarian cancer (HGSOC).Patients with HGSOC were enrolled from May 2017 to Dec
Autor:
Bing, Liu, Zhen, Sun, Zi-Liang, Xu, Hong-Liang, Zhao, Di-Di, Wen, Yong-Ai, Li, Fan, Zhang, Bing-Xin, Hou, Yi, Huan, Li-Chun, Wei, Min-Wen, Zheng
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
Prognostic biomarkers that can reliably predict the disease-free survival (DFS) of locally advanced cervical cancer (LACC) are needed for identifying those patients at high risk for progression, who may benefit from a more aggressive treatment. In th
Publikováno v:
Experimental Animals
Serous borderline ovarian tumors (SBOTs) behave between benign cystadenomas and carcinomas, and the effective detection and clinical management of SBOTs remain clinical challenges. Because it is difficult to isolate and enrich borderline tumor cells,
Publikováno v:
Journal of Magnetic Resonance Imaging. 49:1684-1693
BACKGROUND Due to the overlapping imaging appearances between borderline and malignant epithelial ovarian tumors (EOTs), borderline EOTs often represent a diagnostic challenge on conventional MRI. Proton magnetic resonance spectroscopy (1 H-MRS) migh
Publikováno v:
Translational Oncology, Vol 10, Iss 3, Pp 311-317 (2017)
Translational Oncology
Translational Oncology
Lung cancer is the most common fatal malignancy for both men and women and adenocarcinoma is the most common histologic type. Early diagnosis of lung cancer can significantly improve the survival rate of patients. This study aimed to investigate the
Autor:
Guo Fu Zhang, Shu Hui Zhao, Wei Yong Gu, Yong Ai Li, Feng Feng, Feng Hua Ma, Hai Ming Li, Jin Wei Qiang
Publikováno v:
Journal of Magnetic Resonance Imaging. 46:1499-1506
PURPOSE To investigate the use of diffusion kurtosis imaging (DKI) in differentiating borderline from malignant epithelial ovarian tumors (MEOTs) and to correlate DKI parameters with Ki-67 expression. MATERIALS AND METHODS Fifty-two consecutive patie
Publikováno v:
European journal of radiology. 98
Purpose To identify the MRI features of borderline epithelial ovarian tumors (BEOTs) and to differentiate BEOTs from malignant epithelial ovarian tumors (MEOTs). Materials and methods The clinical and MRI data of 89 patients with a BEOT and 109 patie